Your browser doesn't support javascript.
loading
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study.
Jaworski, Janusz; Matucci-Cerinic, Marco; Schulze-Koops, Hendrik; Buch, Maya H; Kucharz, Eugeniusz J; Allanore, Yannick; Kavanaugh, Arthur; Young, Philip; Babic, Goran.
Afiliação
  • Jaworski J; Reumatika-Centrum Reumatologii, 02-691, Warsaw, Poland. januszjaworski@ymail.com.
  • Matucci-Cerinic M; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy.
  • Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians-University, Munich, Germany.
  • Buch MH; Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Kucharz EJ; Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
  • Allanore Y; Cochin Hospital, Rheumatology A department, Paris Descartes University, Paris, France.
  • Kavanaugh A; UC San Diego School of Medicine, La Jolla, CA, USA.
  • Young P; Hexal AG, a Sandoz company, Holzkirchen, Germany.
  • Babic G; Hexal AG, a Sandoz company, Holzkirchen, Germany.
Arthritis Res Ther ; 21(1): 130, 2019 05 28.
Article em En | MEDLINE | ID: mdl-31138316

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Etanercepte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares / Etanercepte Idioma: En Ano de publicação: 2019 Tipo de documento: Article